Bio Tech & Pharma InhaleRx Secures $38.5 Million in Funding to Support Clinical Development InitiativesBy Alexander LeeOctober 21, 20240 The commitment to advancing the development of bexicaserin for patients with Developmental and Epileptic Encephalopathies (DEEs) is emphasized by Dr.…
